Tue 9 February 2010
The vaccines > HPV > About the HPV vaccine
Why was Cervarix chosen rather than Gardisil for the national programme?
Cervarix®, the HPV vaccine manufactured by GlaxoSmithKline, was selected because the bid from this company scored higher than the competitor in the adjudication process against pre-agreed award
criteria. The pre-agreed award criteria were shared with the manufacturers during the process so that they were fully informed of the criteria against which their bids would be evaluated.
For more information on the tendering process please see:
Information on the tendering process for HPV Vaccine
Real life cervical cancer stories
Abigail, 14, found out that her mum Julie had cervical cancer just after New Year 2008
Information materials
